Release Date: 23/08/16 09:35 Summary: Appendix 4E and FY16 Results Commentary-TOX.AX Price Sensitive: Yes Download Document 723.06KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status